UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions

Cancer Immunology, Immunotherapy, 2008-07, Vol.57 (7), p.951-961

2008

Volltextzugriff (PDF)

Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck

Cytokine (Philadelphia, Pa.), 2004-03, Vol.25 (5), p.220-228

2004

Volltextzugriff (PDF)

Local production of antigen-specific IgE in different anatomic subsites of allergic fungal rhinosinusitis patients

Otolaryngology-head and neck surgery, 2009-07, Vol.141 (1), p.97-103

2009

Volltextzugriff (PDF)

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e007364

2024

Volltextzugriff (PDF)

Chemokine receptor expression in non-melanoma skin cancer

Journal of cutaneous pathology, 2008-07, Vol.35 (7), p.623-629

2008

Volltextzugriff (PDF)

Effects of housing density on weight gain, immune function, behavior, and plasma corticosterone concentrations in BALB/c and C57BL/6 mice

Journal of the American Association for Laboratory Animal Science, 2008-03, Vol.47 (2), p.16-23

2008

Volltextzugriff (PDF)

Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma

Otolaryngology-head and neck surgery, 2004-11, Vol.131 (5), p.573-576

2004

Volltextzugriff (PDF)

Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma

Current treatment options in oncology, 2007-06, Vol.8 (3), p.227-238

2007

Volltextzugriff (PDF)

BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study

JTO clinical and research reports, 2022-11, Vol.3 (11), p.100400-100400, Article 100400

2022

Volltextzugriff (PDF)

Local IgE production in nonatopic nasal polyposis

Journal of otolaryngology-head and neck surgery, 2010-02, Vol.39 (1), p.45-51

2010

Volltextzugriff (PDF)

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

Human immunology, 2003-12, Vol.64 (12), p.1160-1166

2003

Volltextzugriff (PDF)

Autocrine motility-stimulatory pathways of oral premalignant lesion cells

Clinical & experimental metastasis, 2007-04, Vol.24 (2), p.131-139

2007

Volltextzugriff (PDF)

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34 + progenitor cells

Human immunology, 2001-04, Vol.62 (4), p.332-341

2001

Volltextzugriff (PDF)

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

Clinical cancer research, 2021-01, Vol.27 (2), p.460-472

2021

Volltextzugriff (PDF)

Combination Docetaxel plus Vitamin D3 as an Immune Therapy in Animals Bearing Squamous Cell Carcinomas

Otolaryngology-head and neck surgery, 2005-10, Vol.133 (4), p.611-618

2005

Volltextzugriff (PDF)

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma

American journal of hematology, 2020-05, Vol.95 (5), p.510-520

2020

Volltextzugriff (PDF)

Combination Docetaxel Plus Vitamin D 3 as an Immune Therapy in Animals Bearing Squamous Cell Carcinomas

Otolaryngology-head and neck surgery, 2005-10, Vol.133 (4), p.611-618

2005

Volltextzugriff (PDF)

Antigen-specific IgE in sinus mucosa of allergic fungal rhinosinusitis patients

American journal of rhinology, 2008-09, Vol.22 (5), p.451-456

2008

Volltextzugriff (PDF)

Dendritic cell development from mobilized peripheral blood CD34+ cells

Methods in molecular biology (Clifton, N.J.), 2003, Vol.215, p.409

2003

Volltextzugriff (PDF)

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3

Cancer Immunology, Immunotherapy : CII, 2004-05, Vol.53 (5), p.422-430

2004

Volltextzugriff (PDF)

Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients

Journal of leukocyte biology, 1999-05, Vol.65 (5), p.623-628

1999

Volltextzugriff (PDF)

CD34+ Immune Suppressive Cells in the Peripheral Blood of Patients with Head and Neck Cancer

Annals of otology, rhinology & laryngology, 2000-08, Vol.109 (8), p.749-754

2000

Volltextzugriff (PDF)

Impact of aging on immune modulation by tumor

Cancer Immunology, Immunotherapy, 2001-08, Vol.50 (6), p.315-320

2001

Volltextzugriff (PDF)

Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT034-CT034

2023

Volltextzugriff (PDF)

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D 3

Cancer Immunology, Immunotherapy, 2004-05, Vol.53 (5), p.422-430

2004

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(50)
Dissertationen
(1)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Humans
(25)
Immunology
(13)
Female
(12)
Animals
(11)
Carcinoma, Squamous Cell - Pathology
(11)
Oncology
(11)
Otorhinolaryngology
(11)
Biological And Medical Sciences
(10)
Head And Neck Neoplasms - Pathology
(10)
Medical Sciences
(9)
Cancer
(7)
Dendritic Cells
(7)
Male
(7)
Mice
(7)
Middle Aged
(7)
Aged
(6)
Carcinoma, Squamous Cell - Blood
(6)
Carcinoma, Squamous Cell - Immunology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions

Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck

Local production of antigen-specific IgE in different anatomic subsites of allergic fungal rhinosinusitis patients

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

Chemokine receptor expression in non-melanoma skin cancer

Effects of housing density on weight gain, immune function, behavior, and plasma corticosterone concentrations in BALB/c and C57BL/6 mice

Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma

Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma

BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study

Local IgE production in nonatopic nasal polyposis

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

Autocrine motility-stimulatory pathways of oral premalignant lesion cells

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34 + progenitor cells

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

Combination Docetaxel plus Vitamin D3 as an Immune Therapy in Animals Bearing Squamous Cell Carcinomas

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma

Combination Docetaxel Plus Vitamin D 3 as an Immune Therapy in Animals Bearing Squamous Cell Carcinomas

Antigen-specific IgE in sinus mucosa of allergic fungal rhinosinusitis patients

Dendritic cell development from mobilized peripheral blood CD34+ cells

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3

Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients

CD34+ Immune Suppressive Cells in the Peripheral Blood of Patients with Head and Neck Cancer

Impact of aging on immune modulation by tumor

Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D 3

Suchergebnisse filtern